Search Results 61-70 of 17391 for hba1c
Certain factors, such as nerve damage (diabetic neuropathy), arterial disease and obesity, may cause these problems — but often the cause isn't clear. Learn ...
HbA1c ≥ 9.5% within 90 days before Day 1. LDL cholesterol ≥ 190 mg/dL and already on a stable dose of LDL-lowering medication for ≥ 30 days. LDL ...
HbA1c 6.5% -9.5%; FPG ≥126 mg/dL (7.0 mmol/L) <270 mg/dl at screening; 25 to 60 years of age; BMI 22-37 kg/m². Exclusion Criteria. Diabetic meds other than ...
Patients with decompensated diabetes (HbA1c>9%). Patients with a history of clinically significant acute cardiac event within 6 months prior to screening ...
The purpose of this study is to assess the effectiveness of Revita® DMR for improving HbA1c to ≤ 7% without the need of insulin in subjects with T2D ...
Participation eligibility · T1DM or T2DM of duration ≥ 5 years. · HbA1C > 7.5 %. · Able to provide written informed consent before participating in the study.
Understand why weight gain is linked to insulin treatment, and find out how to dodge those extra pounds while still managing your blood sugar.
Participation eligibility · Same treatment regimen (MDI, an AID system, or an insulin pump without automation) for the 3 months prior to screening: · HbA1c < 11.0 ...
HbA1c ≤ 10%; On insulin pump therapy for at least six months; no symptomatic gastroparesis; no unstable retinopathy (requiring photocoagulation within past 6 ...
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day,. All-Cause Unplanned Readmission (HWR) Rate for MIPS ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.